misonneh's pharmacogenetics [126 articles] Export

Recent papers added to misonneh's library classified by the tag pharmacogenetics. You can also see everyone's pharmacogenetics.

Hide details

	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 265-269. by L. W. Chinn, D. L. Kroetz posted to review pharmacogenetics mdr1 by misonneh on 2009-11-19 05:48:32 as
	Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 170-177. by L. J. Lesko posted to pharmacogenetics perspective design comments by misonneh on 2009-11-19 05:41:44 as along with 1 person rwinegar
	The Prospects for \|[ldquo]\|Personalized Medicine\|[rdquo]\| in Drug Development and Drug Therapy [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 164-169. by J. Woodcock posted to review pharmacogenetics perspective design by misonneh on 2009-11-19 05:39:07 as
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Genomics: We are individuals [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (01 November 2009), pp. 770-771. by Gemma K. Alderton posted to technology subtypes pharmacogenetics metastasis genetics dynamic comments breast biomarker by misonneh on 2009-11-19 02:18:41 as
	Current Understanding of the Pharmacogenomics of Metformin [My Copy] Clinical Pharmacology & Therapeutics, Vol. 86, No. 6. (01 December 2009), pp. 595-598. by O. Zolk posted to transport review pharmacogenetics metformin comments by misonneh on 2009-11-18 02:40:31 as
	The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB). [My Copy] Clinical pharmacology and therapeutics, Vol. 82, No. 4. (22 October 2007), pp. 472-475. by R. P. Owen, T. E. Klein, R. B. Altman posted to pharmacogenetics database by misonneh on 2009-11-10 08:28:55 as along with 1 person psique
	The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge. [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 1. (January 2007), pp. 21-24. by A. E. Hodge, R. B. Altman, T. E. Klein posted to pharmacogenetics database by misonneh on 2009-11-10 08:28:02 as
	PharmGED: pharmacogenetic effect database. [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 1. (January 2007) by B. Xie, C. J. Zheng, L. Y. Han, et al.S. Ong, J. Cui, H. L. Zhang, L. Jiang, X. Chen, Y. Z. Chen posted to pharmacogenetics database by misonneh on 2009-11-10 08:27:41 as
	The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. [My Copy] Nucleic acids research, Vol. 36, No. Database issue. (January 2008) by Tina Hernandez-Boussard, Michelle Whirl-Carrillo, Joan M. Hebert, et al.Li Gong, Ryan Owen, Mei Gong, Winston Gor, Feng Liu, Chuong Truong, Ryan Whaley, Mark Woon, Tina Zhou, Russ B. Altman, Teri E. Klein posted to review pharmacogenetics database by misonneh on 2009-11-10 08:25:18 as along with 1 person guhjy
	Data integration and genomic medicine. [My Copy] Journal of biomedical informatics, Vol. 40, No. 1. (February 2007), pp. 5-16. by Brenton Louie, Peter Mork, Fernando Martin-Sanchez, Alon Halevy, Peter Tarczy-Hornoch posted to review pharmacogenetics database data_mining by misonneh on 2009-11-10 08:06:10 as along with 2 people dansullivanblk guhjy
	Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3494-3502. by Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Georg Hutarew, Roland Reitsamer, Robin L. Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter posted to response prediction pharmacogenetics neurod1 neoadjuvant methylation gene_specific_methylation epigenetics circ_dna chemotherapy breast by misonneh on 2009-11-04 21:21:37 as
	The effect of genetic variability on drug response in conventional breast cancer treatment. [My Copy] European journal of pharmacology (18 October 2009) by Emilia Wiechec, Lise Lotte L. Hansen posted to review response pharmacogenetics metabolism genetics chemotherapy breast by misonneh on 2009-10-29 07:12:29 as
	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen. [My Copy] Cancer, Vol. 115, No. 5. (1 March 2009), pp. 952-961. by Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim, Kenzo Shimazu, Yasuhiro Tamaki, Shinzaburo Noguchi posted to tamoxifen pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:17:16 as along with 2 people ilsun Mi-Seon
	Impact of CYP2D610 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. [My Copy] Cancer science*, Vol. 99, No. 5. (May 2008), pp. 995-999. by Kazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.Yoshimi Bando, Ikuko Sumitomo, Naoya Hosono, Michiaki Kubo, Yusuke Nakamura, Hitoshi Zembutsu posted to pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:12:50 as
	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 23. (3 December 2003), pp. 1758-1764. by Vered Stearns, Michael D. Johnson, James M. Rae, et al.Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism ddi breast by misonneh on 2009-10-27 07:02:30 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen prognosis prediction pharmacogenetics genotype cyp2d6 breast by misonneh on 2009-10-26 06:36:40 as along with 2 people songpku merpublic
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Development of the 21-gene assay and its application in clinical practice and clinical trials. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 5. (10 February 2008), pp. 721-728. by Joseph A. Sparano, Soonmyung Paik posted to review randomized_controlled_trial pharmacogenetics oncotypedx genetics design clinic biomarker by misonneh on 2009-10-13 01:05:56 as along with 1 person frohike
	The impact of FDA guidance on pharmacogenomic data submissions on drug development. [My Copy] IDrugs : the investigational drugs journal, Vol. 8, No. 8. (August 2005), pp. 648-650. by Stephen Little posted to pharmacogenetics guideline fda drug_discovery by misonneh on 2009-10-12 22:36:59 as
	Pharmacogenetics in drug discovery and development: a translational perspective. [My Copy] Nature reviews. Drug discovery, Vol. 7, No. 10. (19 October 2008), pp. 807-817. by Allen D. Roses posted to translation review pharmacogenetics drug_discovery by misonneh on 2009-10-12 22:09:29 as along with 5 people guhjy nicklynch pengchy sg45653 dunnma
	Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels [My Copy] (February 2009) posted to summary pharmacogenetics fda biomarker by misonneh on 2009-10-11 02:14:54 as
	E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories [My Copy] (April 2008) posted to pharmacogenetics guideline fda by misonneh on 2009-10-11 01:37:40 as
	Guidance on Pharmacogenetic Tests and Genetic Tests for Heritable Markers [My Copy] (19 June 2007) by Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research posted to pharmacogenetics guideline fda by misonneh on 2009-10-11 01:18:53 as
	A pharmacogene database enhanced by the 1000 Genomes Project. [My Copy] Pharmacogenetics and genomics (9 September 2009) by Eric R. Gamazon, Wei Zhang, R. S. Huang, M. E. Dolan, Nancy J. Cox posted to pharmacogenetics database by misonneh on 2009-10-08 03:30:21 as
	MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 2. (15 January 2008), pp. 360-365. by Aoife J. Lowery, Nicola Miller, Roisin E. McNeill, Michael J. Kerin posted to review prognosis pharmacogenetics mirna breast by misonneh on 2009-10-06 20:13:54 as along with 1 person giovenko
	Role of Anthracyclines in the Treatment of Early Breast Cancer [My Copy] J Clin Oncol, Vol. 27, No. 28. (1 October 2009), pp. 4798-4808. by Luca Gianni, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, Gabriel N. Hortobagyi posted to review prognosis pharmacogenetics genetics clinic chemotherapy breast biomarker anthracycline by misonneh on 2009-09-30 04:37:43 as
	Pharmacogenetics - five decades of therapeutic lessons from genetic diversity. [My Copy] Nature reviews. Genetics, Vol. 5, No. 9. (September 2004), pp. 669-676. by Urs A. Meyer posted to review pharmacogenetics history by misonneh on 2009-09-29 18:42:53 as along with 1 person raiyar
	Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. [My Copy] Pharmacotherapy, Vol. 28, No. 8. (August 2008), pp. 992-998. by Felix W. Frueh, Shashi Amur, Padmaja Mummaneni, et al.Robert S. Epstein, Ronald E. Aubert, Teresa M. DeLuca, Robert R. Verbrugge, Gilbert J. Burckart, Lawrence J. Lesko posted to summary pharmacogenetics fda biomarker by misonneh on 2009-09-29 18:31:30 as
	Personalized medicine: elusive dream or imminent reality? [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 6. (June 2007), pp. 807-816. by L. J. Lesko posted to review pharmacogenetics fda comments by misonneh on 2009-09-29 18:29:20 as along with 2 people junbo_yin PredictER
	International Serious Adverse Events Consortium [My Copy] posted to pharmacogenetics consortium adr by misonneh on 2009-09-29 18:22:41 as
	Pharmacogenomics and drug toxicity. [My Copy] The New England journal of medicine, Vol. 359, No. 8. (21 August 2008), pp. 856-858. by Yusuke Nakamura posted to pharmacogenetics comments adr by misonneh on 2009-09-29 18:18:37 as along with 1 person Amazoness
	SLCO1B1 variants and statin-induced myopathy--a genomewide study. [My Copy] The New England journal of medicine, Vol. 359, No. 8. (21 August 2008), pp. 789-799. by SEARCH Collaborative Group, E. Link, S. Parish, et al.J. Armitage, L. Bowman, S. Heath, F. Matsuda, I. Gut, M. Lathrop, R. Collins posted to statin slco1b1 pharmacogenetics gwas adr by misonneh on 2009-09-29 18:18:08 as along with 1 person michellerouge
	Pharmacogenomics: challenges and opportunities. [My Copy] Annals of internal medicine, Vol. 145, No. 10. (21 November 2006), pp. 749-757. by Dan M. Roden, Russ B. Altman, Neal L. Benowitz, et al.David A. Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner, Richard M. Weinshilboum, Scott T. Weiss, Pharmacogenetics Research Network posted to review pharmacogenetics perspective adr by misonneh on 2009-09-29 18:13:22 as along with 1 person guhjy
	Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. [My Copy] The New England journal of medicine, Vol. 358, No. 6. (7 February 2008), pp. 637-639. by Magnus Ingelman-Sundberg posted to pharmacogenetics comments adr by misonneh on 2009-09-29 17:46:44 as
	Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? [My Copy] Clinical genetics, Vol. 56, No. 4. (October 1999), pp. 247-258. by D. W. Nebert posted to review pharmacogenetics clinic by misonneh on 2009-09-29 17:35:02 as
	The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? [My Copy] Genetics in medicine : official journal of the American College of Medical Genetics, Vol. 9, No. 10. (October 2007), pp. 665-674. by Muin J. Khoury, Marta Gwinn, Paula W. Yoon, Nicole Dowling, Cynthia A. Moore, Linda Bradley posted to translation review prevention pharmacogenetics integration by misonneh on 2009-09-29 17:33:03 as along with 2 people jasonbobe PredictER
	MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. [My Copy] Pharmacogenomics, Vol. 10, No. 3. (March 2009), pp. 399-416. by Prasun J. Mishra, Joseph R. Bertino posted to review pharmacogenetics mirna genetics epigenetics epidemiology by misonneh on 2009-09-29 17:17:42 as along with 2 people guhjy daforerog
	No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 18, No. 9. (September 2009), pp. 2562-2564. by Thomas P. Ahern, Lars Pedersen, Deirdre P. Cronin-Fenton, Henrik T. SÃ¸rensen, Timothy L. Lash posted to tamoxifen pharmacogenetics ddi cyp2d6 breast by misonneh on 2009-09-25 06:27:56 as
	Pharmacogenetics and pharmacogenomics: development, science, and translation. [My Copy] Annual review of genomics and human genetics, Vol. 7 (2006), pp. 223-245. by Richard M. Weinshilboum, Liewei Wang posted to translation review pharmacogenetics by misonneh on 2009-09-19 09:44:13 as
	Pharmacogenomics: candidate gene identification, functional validation and mechanisms. [My Copy] Human molecular genetics, Vol. 17, No. R2. (15 October 2008) by Liewei Wang, Richard M. Weinshilboum posted to translation review pharmacogenetics by misonneh on 2009-09-19 09:43:36 as
	PharmGKB: an integrated resource of pharmacogenomic data and knowledge. [My Copy] Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis ... [et al.], Vol. Chapter 14 (September 2008) by Li Gong, Ryan P. Owen, Winston Gor, Russ B. Altman, Teri E. Klein posted to pharmacogenetics database by misonneh on 2009-09-15 10:20:43 as along with 1 person dullhunk
	Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. [My Copy] Pharmacogenetics and genomics, Vol. 18, No. 5. (May 2008), pp. 390-402. by Chin-Chuan C. Hung, Chih-Chuan C. Chen, Chun-Jung J. Lin, Horng-Huei H. Liou posted to phenotype pharmacogenetics mdr1 genetics epilepsy by misonneh on 2009-09-13 15:25:48 as
	Recent development in pharmacogenomics: from candidate genes to genome-wide association studies. [My Copy] Expert review of molecular diagnostics, Vol. 7, No. 4. (July 2007), pp. 371-393. by Struan F. Grant, Hakon Hakonarson posted to review pharmacogenetics pathway gwas by misonneh on 2009-09-12 17:55:50 as
	Epilepsy pharmacogenetics. [My Copy] Pharmacogenomics, Vol. 10, No. 5. (May 2009), pp. 817-836. by Dalia Kasperaviciūte, Sanjay M. Sisodiya posted to review response resistance pharmacogenetics epilepsy adr by misonneh on 2009-09-03 07:14:45 as
	Environment-mediated drug resistance: a major contributor to minimal residual disease [My Copy] Nat Rev Cancer, Vol. 9, No. 9. (September 2009), pp. 665-674. by Mark B. Meads, Robert A. Gatenby, William S. Dalton posted to review resistance pharmacogenetics perspective environment by misonneh on 2009-08-26 11:58:51 as along with 1 person songpku

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/pharmacogenetics

Result page: 1 2 3 Next

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's pharmacogenetics [126 articles] Export

misonneh's tags